DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, announced that it has signed two new contracts in the employer and provider markets; these new contracts serve as indicators of the company’s success in winning busiess in these sectors. The contracts, which are expected to begin in Q2 2022, will implement Dario’s digital therapeutic platform that integrates digital tools, medical devices, and digital and human coaching across one experience. Through Dario, employees can more effectively change their behavior to better manage their chronic conditions. According to the announcement, the new employer client will deploy Dario’s digital behavioral solution to improve access to outcomes-based care, while the new provider contract includes both diabetes and hypertension solutions. “Dario’s steady increase of clients reinforces our position as a leader in the digital health market and helps to drive future demand for our hyper-personalized solutions,” said DarioHealth president and general manager of North Americ Rick Anderson in the press release. “As we prepare to launch these new clients on Dario’s digital therapeutics platform, we are excited to give these new populations access to solutions that will have a meaningful impact on their lives.”
To view the full press release, visit https://ibn.fm/ofI3T
About DarioHealth Corp.
DarioHealth Corp. is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. DarioHealth offers one of the most comprehensive digital therapeutics solutions on the market, covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform. Dario’s next-generation, AI-powered, digital therapeutic platform supports more than just an individual’s disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions; intuitive, clinically proven digital tools; high-quality software; and coaching to help individuals improve health and sustain meaningful outcomes. Dario’s unique user-centric approach to product design and engagement creates an unparalleled experience that is highly rated by users and delivers sustainable results. Dario’s cross-functional team operates at the intersection of life sciences, behavioral science and software technology, and utilizes a performance-based approach to improve its users’ health. On the path to better health, Dario makes the right thing to do the easy thing to do. For more information about the company, please visit www.DarioHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
